Bedford, Texas | United States
Main Specialties: Statistics
Stephen (Steve) Eason has been with Carter BloodCare for more than 14 years, leading the blood centers Population Health Initiatives program which aims to provide early identification, notification and education of health risks in all blood donors with an emphasis on cardiovascular disease and diabetes risk in high school age blood donors. Steve serves on national committees with the American Association of Blood Banks and America’s Blood Center’s. He is an adjunct instructor with the University of North Texas Health Science Center (UNTHSC), Department of Health Management and Policy in the School of Public Health.
Primary Affiliation: Carter BlodoCare - Bedford, Texas , United States
PubMed Central Citations
1PubMed Central Citations
Diab Vasc Dis Res 2015 Jul 13;12(4):272-8. Epub 2015 May 13.
Carter BloodCare, Bedford, TX, USA Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Transfusion 51(4): 731-736
BACKGROUND: There is an increasing number of blood programs giving donors information about health risks for cardiovascular disease based on a total nonfasting cholesterol level measured at donation. STUDY DESIGN AND METHODS: Experience with screening 187,714 individual donors for total nonfasting cholesterol was reviewed and results were compared with those for a representative sample of United States adults as published in National Health and utrition Examination Surveys. Donors were invited to retrieve their results and were tracked as to whether they used this service or not. RESULTS: By comparison with the national surveys, more blood donors have normal total nonfasting cholesterols and fewer have borderline high or high values as defined by the National Cholesterol Education Program Expert Panel. These observations hold for both males and females across all age ranges from 20 to older than 75 years. Only a minority of donors retrieve their results. CONCLUSIONS: The blood donor setting can be expanded, by inclusion of total nonfasting cholesterol level, to include screening for ardiovascular disease risk. When compared with the general adult population, donors represent a group at less risk for heart disease.